Cargando…
The new German evidence-based guideline on diffuse large B-cell lymphoma—key aspects for radiation oncologists
PURPOSE: Diffuse large B‑cell lymphoma (DLBCL) is an aggressive lymphoma subtype treated successfully with immunochemotherapy. However, there are conflicting data on the role and impact of consolidative radiation therapy (RT). The publication of the national evidence-based guideline on DLBCL prompte...
Autores principales: | Oertel, Michael, Berdel, Christian, Held, Gerhard, Herfarth, Klaus, Schmidberger, Heinz, Ernst, Moritz, Lenz, Georg, Borchmann, Peter, Eich, Hans Theodor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877084/ https://www.ncbi.nlm.nih.gov/pubmed/36598520 http://dx.doi.org/10.1007/s00066-022-02035-9 |
Ejemplares similares
-
P093: From involved- field to involved-node – Quality analysis of the radiation therapy in HD 17 by the expert panel of the German Hodgkin Study Group
por: Oertel, Michael, et al.
Publicado: (2022) -
Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern Era
por: Oertel, Michael, et al.
Publicado: (2022) -
Radiotherapy in Follicular Lymphoma Staged by (18)F-FDG-PET/CT: A German Monocenter Study
por: Karsten, Imke E., et al.
Publicado: (2021) -
P092: Estimating the dosimetric benefit of involved-node radiotherapy in comparison to involved-field radiotherapy - implications from the GHSG HD 17 trial
por: Oertel, Michael, et al.
Publicado: (2022) -
P097: The status quo of involved-field radiotherapy – Quality analysis of radiotherapy in the GHSG HD 16
por: Oertel, Michael, et al.
Publicado: (2022)